Dasatinib Tablet
Product Images NDC 59651-545

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Dasatinib (NDC 59651-545). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (20 mg (60 Tablet Bottle))

This is a description of Dasatinib Tablets, each containing 20 mg of Dasatinib, issued by Aurobindo Pharma USA, Inc. It is advised not to crush, cut, or chew the tablets but to swallow them whole. The package insert contains dosage instructions, directions for use, and precautions. The tablets should be stored at 20° to 25°C and kept away from temperatures of 15° to 30°C. Do not use if the inner seal of the bottle is broken or missing. This medication is distributed by Aurobindo Pharma USA, Inc. from East Windsor, NJ, and manufactured in India.*

FDA Label Image

Package Label-principal Display Panel (100 mg 15 (1x15) Unit-dose Tablets)

This text provides information regarding Dasatinib Tablets, with each film-coated tablet containing 100 mg of the medication. The usual dosage instructions, storage conditions, and precautions are highlighted. It states not to crush, cut, or chew the tablet but to swallow it whole. The package is not child-resistant. Rxonly is mentioned on the package, and storage should be done at 20°to 25°C (68°to 77°F).*

FDA Label Image

Package Label-principal Display Panel (140 mg (30 Tablet Bottle))

FDA Label Image

Package Label-principal Display Panel (140 mg 15 (1x15) Unit-dose Tablets)

Each film-coated tablet contains 140 mg of Dasatinib. The usual dosage should be followed as per the instructions provided in the package insert. Store the tablets in a temperature range of 20° to 25° (68° to 77°F), with excursions permitted between 59° to 86°F. These Dasatinib tablets come in a pack of 15 (1x15) unit-dose tablets. Do not crush, cut, or chew the tablets; swallow them whole. Remember, this product is available by prescription only.*

FDA Label Image

Package Label-principal Display Panel (20 mg 15 (1x15) Unit-dose Tablets)

This is a description of Dasatinib Tablets, each pack containing 15 tablets in a unit dose pack. The tablets should not be crushed, cut, or chewed; they should be swallowed whole. The recommended dosage is specified on the package, and the storage temperature range is provided. The medication must be used based on the prescription and instructions from the healthcare provider.*

FDA Label Image

Package Label-principal Display Panel (50 mg (60 Tablet Bottle))

This is an evaluation text.*

FDA Label Image

Package Label-principal Display Panel (50 mg 15 (1x15) Unit-dose Tablets)

This text provides information about Dasatinib tablets containing 50 mg of the active ingredient. It includes guidelines on dosage, storage conditions, and usage instructions. The tablets should be swallowed whole and not crushed, cut, or chewed. The product is offered in a unit-dose package and is prescription-only. Storage should be at 20° to 25°C with permissible excursions between 15° to 30°C. Additional details such as package insert, dosing instructions, and precautions are available.*

FDA Label Image

Package Label-principal Display Panel (70 mg (60 Tablet Bottle))

Description: This text provides information about 70 mg Dasatinib film-coated tablets distributed by Aurobindo Pharma USA, Inc. It includes details on dosage, storage instructions, precautions, and not to be used if inner seal is broken. The text also mentions the product's NDC number, dosage instructions, and company address in East Windsor, NJ.*

FDA Label Image

Package Label-principal Display Panel (70 mg 15 (1x15) Unit-dose Tablets)

The provided text seems to be labeling information for Dasatinib 70 mg film-coated tablets. It mentions the usual dosage, storage conditions, and instructions not to crush, cut, or chew the tablets but swallow them whole. The package contains 15 unit-dose tablets and is not child-resistant. It also includes the National Drug Code (NDC) for identification. For detailed dosing information and precautions, refer to the package insert.*

FDA Label Image

Package Label-principal Display Panel (80 mg (30 Tablet Bottle))

FDA Label Image

Package Label-principal Display Panel (80 mg 15 (1x15) Unit-dose Tablets)

This is a product description for Dasatinib Tablets, containing 80 mg of Dasatinib per film-coated tablet. The usual dosage instructions are included in the package insert. It is advised to store the tablets at 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). Each pack contains 15 unit-dose tablets, and it is essential not to crush, cut, or chew the tablets; they should be swallowed whole.*

FDA Label Image

Package Label-principal Display Panel (100 mg (30 Tablet Bottle))

This text provides information about a medication called "Dasatinib Tablets" containing 100 mg of Cininin distributed by Aurobindo Pharma USA, Inc. It includes dosing instructions, storage conditions, and precautions. The recommended dosage can be found in the package insert. The tablets should be stored at 20° to 25°C and should not be crushed, cut, or chewed. It advises against using the tablets if the inner seal of the bottle is broken or missing. The code mentioned is TS/DRUGS/24/2015. Overall, it is essential to follow the provided guidelines for the safe and effective use of this medication.*

FDA Label Image

Chemical-structure (Dasatinib Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.